제1형 당뇨병에서 만성 신장 질환과 당뇨병성 케톤산증 위험

Bakhsh 외 (화요일), 이 질문을 연구했습니다.

synapsesocial.com/papers/69a75a78c6e9836116a204de — DOI: https://doi.org/10.2337/dc25-1955

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase· 1986 · 332 citations
2. Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease· 2022 · 83 citations
3. Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease· 2023 · 46 citations
4. People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action· 2023 · 37 citations
5. The Long-Term Incidence of Hospitalization for Ketoacidosis in Adults with Established T1D—A Prospective Cohort Study· 2019 · 30 citations